Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.

减少氧代谢以减少缺氧并使肿瘤放射增敏。

基本信息

批准号：
8893910
负责人：
Nicholas C. Denko
金额：
$ 31.64万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-09-25 至 2016-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8893910
关键词：
Acetyl Coenzyme A Back Biguanides Biochemical Bioenergetics Biological Assay Bypass Carbohydrates Cell Culture Techniques Cell Survival Cells Clinical Clinical Trials Complex Consumption Data Diffusion Dose Down-Regulation EF5 Electrodes Electron Transport Equilibrium Erythrocytes Family Glucose Glutamine Health Hypoxia Image Immune In Vitro Intervention Irradiated tumor Kinetics Malignant Neoplasms Malignant neoplasm of cervix uteri Malignant neoplasm of lung Malignant neoplasm of pancreas Measures Mediating Metabolic Metabolism Metformin Mitochondria Modeling Mus NADH Normal Cell Normal tissue morphology Oxygen Oxygen Consumption Patients Pharmaceutical Preparations Phenformin Phosphotransferases Physiological Positron-Emission Tomography Protein Kinase Protocols documentation Radiation Radiation therapy Radiosensitization Relative (related person)Rodent Role STK11 gene Testing Time Tissues Toxic effect Translating Tumor Suppressor Proteins Work alpha ketoglutarate cell killing diabetic functional status gain of function glucose uptake in vivo insight irradiation loss of function meetings neoplastic cell radiation resistance radiosensitizing response sensor subcutaneous tumor tumor growth

项目摘要

DESCRIPTION (provided by applicant): Tumor hypoxia has been recognized as a hindrance to successful radiation therapy for over 50 years. Attempts to overcome this obstacle by delivering more oxygen to the tumor, however, have been clinically disappointing, largely due to the functional limitations of the tumor vasculature. Instead of reducing hypoxia by increased delivery of oxygen, this application proposes to limit hypoxia by reducing oxygen consumption within the tumor. If the supply of oxygen delivered to the tumor is constant, then transient reduction in demand will increase overall functional oxygenation. Commonly prescribed anti-diabetic biguanidedrugs (metformin, phenformin) have been shown to reduce mitochondrial function in vitro at least in part through inhibition of electron transport chain (ETC) complex 1. We propose to test the hypothesis that pharmacologic downregulation of mitochondrial metabolism will reduce cellular demand for oxygen and result in decreased tumor hypoxia and specific radiosensitization of model tumors. This approach will be especially effective when using hypofractionated radiation protocols where oxygen enhancement can have a profound effect on overall tumor cell killing. We have organized this proposal into the following four specific aims. 1) Determine the role of tumor suppressor LKB1 in mediating the effect of biguanides on mitochondrial metabolism. 2) Establish the relative importance of glucose versus glutamine as a mitochondrial fuel in regulating mitochondrial response to intervention with biguanides. 3) Quantitate the biochemical effect of biguanides on mitochondrial function, tumor hypoxia, and glucose consumption in vivo. And 4) Establish the optimal level of radiosensitization in both subcutaneous and orthotopic model tumors treated with biguanides and radiation. It is important to note that because normal tissue is typically well oxygenated, thi systemic approach will specifically radiosensitize tumors, without causing enhanced normal tissue toxicity.

描述（由申请人提供）：50 多年来，肿瘤缺氧一直被认为是成功放射治疗的障碍。然而，通过向肿瘤输送更多氧气来克服这一障碍的尝试在临床上令人失望，这主要是由于肿瘤脉管系统的功能限制。该申请提出通过减少肿瘤内的耗氧量来限制缺氧，而不是通过增加氧气输送来减少缺氧。如果输送到肿瘤的氧气供应是恒定的，那么需求的短暂减少将增加整体功能性氧合。常用的抗糖尿病双胍药物（二甲双胍、苯乙双胍）已被证明可以在体外降低线粒体功能，至少部分是通过抑制电子传递链 (ETC) 复合物 1。我们建议检验这样的假设：线粒体代谢的药理下调会降低线粒体功能。细胞对氧气的需求，导致肿瘤缺氧减少和模型肿瘤的特异性放射增敏。当使用大分割放射治疗方案时，这种方法将特别有效，其中氧气增强可以对整体肿瘤细胞杀伤产生深远影响。我们将此提案分为以下四个具体目标。 1)确定抑癌基因LKB1在介导双胍类药物对线粒体代谢的影响中的作用。 2) 确定葡萄糖与谷氨酰胺作为线粒体燃料在调节线粒体对双胍干预的反应中的相对重要性。 3) 定量双胍类药物对线粒体功能、肿瘤缺氧和体内葡萄糖消耗的生化作用。 4) 在用双胍和放射治疗的皮下和原位模型肿瘤中建立最佳放射增敏水平。值得注意的是，由于正常组织通常氧合良好，因此这种全身方法将特异性地使肿瘤放射增敏，而不会导致正常组织毒性增强。